Immunosuppression
This graph shows the total number of publications written about "Immunosuppression" by people in the URMC Research Network by year, and whether "Immunosuppression" was a major or minor topic of these publication.
Below are the most recent publications written about "Immunosuppression" by people in Profiles.
-
Vinh DC, Freeman AF, Shea YR, Malech HL, Abinun M, Weinberg GA, Holland SM. Mucormycosis in chronic granulomatous disease: association with iatrogenic immunosuppression. J Allergy Clin Immunol. 2009 Jun; 123(6):1411-3.
-
Gea-Banacloche JC, Weinberg GA. Monoclonal antibody therapeutics and risk for infection. Pediatr Infect Dis J. 2007 Nov; 26(11):1049-52.
-
Hilchey SP, De A, Rimsza LM, Bankert RB, Bernstein SH. Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells. J Immunol. 2007 Apr 1; 178(7):4051-61.
-
Elad S, Thierer T, Bitan M, Shapira MY, Meyerowitz C. A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantation. Oral Oncol. 2008 Jan; 44(1):37-42.
-
Looney RJ. Discovering that B cells are important in rheumatoid arthritis. J Rheumatol. 2005 Nov; 32(11):2067-9.
-
Zand MS. Immunosuppression and immune monitoring after renal transplantation. Semin Dial. 2005 Nov-Dec; 18(6):511-9.
-
Komrokji RS, Oliva JL, Zand M, Felgar R, Abboud CN. Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders. Am J Hematol. 2005 Jul; 79(3):211-5.
-
Flechner SM, Feng J, Mastroianni B, Savas K, Arnovitz J, Moneim H, Modlin CS, Goldfarb D, Cook DJ, Novick AC. The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free immunosuppression. Transplantation. 2005 Apr 27; 79(8):926-34.
-
Jain A, Marcos A, Reyes J, Mazariagos G, Kashyap R, Eghtesad B, Marsh W, Fontas P, De Vera M, Costa G, Patel K, Gadomski M, Starzl T, Fung J. Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. Transplant Proc. 2005 Mar; 37(2):1207-10.
-
Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005 May 15; 105(10):3802-11.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
